Table 1A.
Demographic and baseline determinants in patients with or without BK viruria at months 6 and 12
| Month 6 | Month 12 | |||||||
|---|---|---|---|---|---|---|---|---|
| Viruria | N | n+ (%) | n− (%) | p | N | n+ (%) | n− (%) | p |
| Total | 558 | 142 (25.4%) | 416 (74.6%) | 462 | 94 (20.3%) | 368 (79.7%) | ||
| Recipient age | 0.552 | 0.253 | ||||||
| <40 years | 183 | 47 (25.7%) | 136 (74.3%) | 156 | 25 (16.0%) | 131 (84.0%) | ||
| 40–54 years | 211 | 58 (27.5%) | 153 (72.5%) | 179 | 41 (22.9%) | 138 (77.1%) | ||
| ≥ 55 years | 164 | 37 (22.6%) | 127 (77.4%) | 127 | 28 (22.0%) | 99 (78.0%) | ||
| Gender | 0.965 | 0.747 | ||||||
| Male | 382 | 97 (25.4%) | 285 (74.6%) | 323 | 67 (20.7%) | 256 (79.3%) | ||
| Female | 176 | 45 (25.6%) | 131 (74.4%) | 139 | 27 (19.4%) | 112 (80.6%) | ||
| Race | 0.811 | 0.836 | ||||||
| White | 468 | 120 (25.6%) | 348 (74.4%) | 395 | 81 (20.5%) | 314 (79.5%) | ||
| Nonwhite | 90 | 22 (24.4%) | 68 (75.6%) | 67 | 13 (19.4%) | 54 (80.6%) | ||
| History of DM | 0.760 | 0.704 | ||||||
| Yes | 87 | 21 (24.1%) | 66 (75.9%) | 68 | 15 (22.1%) | 53 (77.9%) | ||
| No | 471 | 121 (25.7%) | 350 (74.3%) | 394 | 79 (20.1%) | 315 (79.9%) | ||
| HLA mismatches | 0.964 | 0.631 | ||||||
| 0 | 23 | 6 (26.1%) | 17 (73.9%) | 18 | 4 (22.2%) | 14 (77.8%) | ||
| 1–3 | 280 | 70 (25.0%) | 210 (75.0%) | 232 | 51 (22.0%) | 181 (78.0%) | ||
| 4–6 | 254 | 66 (26.0%) | 188 (74.0%) | 212 | 39 (18.4%) | 173 (81.6%) | ||
| DGF | 0.883 | 0.429 | ||||||
| Yes | 96 | 25 (26.0%) | 71 (74.0%) | 76 | 18 (23.7%) | 58 (76.3%) | ||
| No | 462 | 117 (25.3%) | 345 (74.7%) | 386 | 76 (19.7%) | 310 (80.3%) | ||
| Donor status | 0.095 | 0.051 | ||||||
| Living | 185 | 39 (21.1%) | 146 (78.9%) | 152 | 23 (15.1%) | 129 (84.9%) | ||
| Deceased | 373 | 103 (27.6%) | 270 (72.4%) | 310 | 71 (22.9%) | 239 (77.1%) | ||
| Dialysis | 0.738 | 0.820 | ||||||
| None | 57 | 15 (26.3%) | 42 (73.7%) | 47 | 11 (23.4%) | 36 (76.6%) | ||
| Hemodialysis | 406 | 100 (24.6%) | 306 (75.4%) | 335 | 66 (19.7%) | 269 (80.3%) | ||
| Peritoneal | 95 | 27 (28.4%) | 68 (71.6%) | 80 | 17 (21.3%) | 63 (78.8%) | ||
| CMV D/R | 0.857 | 0.661 | ||||||
| Neg./neg. | 100 | 29 (29.0%) | 71 (71.0%) | 78 | 16 (20.5%) | 62 (79.5%) | ||
| Neg./pos. | 99 | 26 (26.3%) | 73 (73.7%) | 90 | 22 (24.4%) | 68 (75.6%) | ||
| Pos./neg. | 70 | 19 (27.1%) | 51 (72.9%) | 57 | 9 (15.8%) | 48 (84.2%) | ||
| Pos./pos. | 248 | 61 (24.6%) | 187 (75.4%) | 201 | 42 (20.9%) | 159 (79.1%) | ||
| HCV D/R | 0.704 | 0.881 | ||||||
| Neg./neg. | 543 | 138 (25.4%) | 405 (74.6%) | 450 | 91 (20.2%) | 359 (79.8%) | ||
| Neg./pos. | 11 | 3 (27.3%) | 8 (72.7%) | 10 | 2 (20.0%) | 8 (80.0%) | ||
| Pos./neg. | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Pos./pos. | 2 | 0 | 2 (100.0%) | 1 | 0 | 1 (100.0%) | ||
| Cold ischemia time | 0.168 | 0.062 | ||||||
| N | 141 | 411 | 93 | 364 | ||||
| Median (h) | 14.3 | 12.0 | 15.0 | 12.0 | ||||
| IQR | (0, 35.5) | (0, 30.0) | (0.3, 35.5) | (0, 29.2) | ||||